DOD Multiple Sclerosis Research Program (MSRP) – Pre-application

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with unit

Memorial Deadline: RIS review not required for pre-application

External Deadline: Monday 10th, June 2024


Description

The Multiple Sclerosis Research Program (MSRP) released the following funding opportunities:

  • Clinical Trial Award
  • The MSRP CTA supports the rapid implementation of clinical trials with the potential to have a
    significant impact on the treatment or management of multiple sclerosis. Clinical trials may be
    designed to evaluate promising new products, pharmacologic agents (drugs or biologics),
    devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may
    range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the
    feasibility or inform the design of more advanced trials, through large-scale trials to determine
    efficacy in relevant patient populations.
  • Exploration – Hypothesis Development Award
  • The MSRP EHDA supports the initial exploration of innovative, high-risk, high-gain, and
    potentially groundbreaking concepts in the MS research field. The studies supported by this
    award mechanism are expected to lay the groundwork for future avenues of scientific
    investigation. The proposed research project should include a well-formulated, testable
    hypothesis based on strong scientific rationale and study design. The presentation of
    preliminary and/or published data is not required.
  • Investigator- Initiated Research Award
  • The MSRP IIRA supports highly rigorous, high-impact research projects that have the potential
    to make an important contribution to MS research, patient care, and/or quality of life. Research
    projects may focus on any phase of research, excluding clinical trials. The rationale for a
    research idea may be derived from laboratory discovery, clinical trial results, population-based
    studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must
    include preliminary and/or published data that are relevant to MS and the proposed research
    project.

To view the funding opportunity announcement and submit a pre-application visit https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=589102

Pre-Application (Preproposal) Submission Deadline: 5:00 p.m. Eastern time (ET),
June 10, 2024
Application Submission Deadline: 11:59 p.m. ET, October 7, 2024


Funding Sources

Department of Defence - United States of America



This opportunity was posted by: RGCS

Last modified: April 26, 2024